Cytogenetic complexity and heterogeneity in intravascular lymphoma.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ genetics
Chromosome Aberrations
Female
Genetic Heterogeneity
Genetic Predisposition to Disease
Humans
Karyotype
Karyotyping
Lymphoma, Extranodal NK-T-Cell
/ genetics
Lymphoma, Large B-Cell, Diffuse
/ genetics
Male
Middle Aged
Phenotype
Progression-Free Survival
Vascular Neoplasms
/ genetics
G-band
cytogenetic abnormality
gene rearrangement
intravascular lymphoma
karyotype
prognosis
Journal
Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
14
03
2020
revised:
26
05
2020
accepted:
09
06
2020
pubmed:
9
8
2020
medline:
30
3
2021
entrez:
9
8
2020
Statut:
ppublish
Résumé
To characterise the karyotypic abnormalities and heterogeneities in intravascular lymphoma (IVL). G-banded karyotyping was performed on biopsy specimens from a single-centre IVL cohort comprising intravascular large B-cell lymphoma (IVLBCL, n=12) and NK/T-cell lymphoma (IVNKTCL, n=1). Five IVLBCL cases and one IVNKTCL case (total 46%) were found to have normal karyotypes, and the cytogenetic abnormalities observed in the other seven IVLBCL cases (54%) were investigated further. These seven karyotypes were uniformly complex with an average of 13 aberrations. The seven cases all had abnormalities involving chromosome 6, with 57% involving structural abnormalities at 6q13, and chromosome 8, with 43% involving abnormalities at 8p11.2. In addition, 71% had aberrations at 19q13. On average, 4.4 chromosomal gains and losses were detected per case. Cytogenetic heterogeneities were observed in six cases (86%) and tetraploidy in three cases (43%). There was no significant difference in progression-free survival (p=0.92) and overall survival (p=0.61) between the IVLBCL cases with complex and normal karyotypes. Approximately half of IVLBCL cases had a highly heterogeneous pattern of karyotypes with different clonal numerical and structural chromosome aberrations.
Identifiants
pubmed: 32763919
pii: jclinpath-2020-206573
doi: 10.1136/jclinpath-2020-206573
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
244-250Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.